Myriad CFO James Evans To Retire

(RTTNews) - Myriad Genetics, Inc. (MYGN) said Monday that that chief financial officer James Evans has notified the company of his intent to retire in order to attend to family health issues.

To ensure a smooth transition, Evans will continue as the company's CFO until a replacement can be found.

Myriad said it will engage a leading executive search firm to conduct a national search and that it will consider both internal and external candidates for the position.

Evans joined Myriad in 1995 as corporate controller and was promoted to vice president of Finance in July of 2005. In November of 2007, he was named chief financial officer, a position he has held for the last seven years.